Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor.

Schmidt, Dorian

Axitinib: A Photoswitchable Approved Tyrosine Kinase Inhibitor. [electronic resource] - ChemMedChem 11 2018 - 2415-2426 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1860-7187

10.1002/cmdc.201800531 doi


Animals
Axitinib--chemical synthesis
Binding Sites
Dose-Response Relationship, Drug
Enzyme Assays
Human Umbilical Vein Endothelial Cells
Humans
Isomerism
Mice
Molecular Docking Simulation
NIH 3T3 Cells
Protein Kinase Inhibitors--chemical synthesis
Ultraviolet Rays
Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors